000826171 001__ 826171
000826171 005__ 20210129225533.0
000826171 0247_ $$2doi$$a10.1371/journal.pone.0167432
000826171 0247_ $$2Handle$$a2128/13452
000826171 0247_ $$2WOS$$aWOS:000392843200017
000826171 0247_ $$2altmetric$$aaltmetric:15066486
000826171 0247_ $$2pmid$$apmid:28006031
000826171 037__ $$aFZJ-2017-00417
000826171 082__ $$a500
000826171 1001_ $$0P:(DE-Juel1)145961$$aDammers, Christina$$b0$$ufzj
000826171 245__ $$aSelection and Characterization of Tau Binding D-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease
000826171 260__ $$aLawrence, Kan.$$bPLoS$$c2016
000826171 3367_ $$2DRIVER$$aarticle
000826171 3367_ $$2DataCite$$aOutput Types/Journal article
000826171 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1484641618_11969
000826171 3367_ $$2BibTeX$$aARTICLE
000826171 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000826171 3367_ $$00$$2EndNote$$aJournal Article
000826171 520__ $$aA variety of neurodegenerative disorders, including Alzheimer disease (AD), are associated with neurofibrillary tangles composed of the tau protein, as well as toxic tau oligomers. Inhibitors of pathological tau aggregation, interrupting tau self-assembly, might be useful for the development of therapeutics. Employing mirror image phage display with a large peptide library (over 109 different peptides), we have identified tau fibril binding peptides consisting of d-enantiomeric amino acids. d-enantiomeric peptides are extremely protease stable and not or less immunogenic than l-peptides, and the suitability of d-peptides for in vivo applications have already been demonstrated. Phage display selections were performed using fibrils of the d-enantiomeric hexapeptide VQIVYK, representing residues 306 to 311 of the tau protein, as a target. VQIVYK has been demonstrated to be important for fibril formation of the full lengths protein and forms fibrils by itself. Here, we report on d-enantiomeric peptides, which bind to VQIVYK, tau isoforms like tau3RD (K19) as well as to full lengths tau fibrils, and modulate the aggregation of the respective tau form. The peptides are able to penetrate cells and might be interesting for therapeutic and diagnostic applications in AD research.
000826171 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000826171 7001_ $$0P:(DE-HGF)0$$aYolcu, Deniz$$b1
000826171 7001_ $$0P:(DE-Juel1)159147$$aKukuk, Laura$$b2$$ufzj
000826171 7001_ $$0P:(DE-Juel1)132029$$aWillbold, Dieter$$b3$$ufzj
000826171 7001_ $$0P:(DE-HGF)0$$aPickhardt, Marcus$$b4
000826171 7001_ $$0P:(DE-HGF)0$$aMandelkow, Eckhard$$b5
000826171 7001_ $$0P:(DE-HGF)0$$aHorn, Anselm H. C.$$b6
000826171 7001_ $$0P:(DE-HGF)0$$aSticht, Heinrich$$b7
000826171 7001_ $$0P:(DE-HGF)0$$aMalhis, Marwa Nidal$$b8
000826171 7001_ $$0P:(DE-HGF)0$$aWill, Nadja$$b9
000826171 7001_ $$0P:(DE-HGF)0$$aSchuster, Judith$$b10
000826171 7001_ $$0P:(DE-Juel1)131999$$aFunke, Aileen$$b11$$eCorresponding author
000826171 773__ $$0PERI:(DE-600)2267670-3$$a10.1371/journal.pone.0167432$$n12$$pe0167432$$tPLoS one$$v11$$x1932-6203$$y2016
000826171 8564_ $$uhttps://juser.fz-juelich.de/record/826171/files/journal.pone.0167432.pdf$$yOpenAccess
000826171 8564_ $$uhttps://juser.fz-juelich.de/record/826171/files/journal.pone.0167432.gif?subformat=icon$$xicon$$yOpenAccess
000826171 8564_ $$uhttps://juser.fz-juelich.de/record/826171/files/journal.pone.0167432.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
000826171 8564_ $$uhttps://juser.fz-juelich.de/record/826171/files/journal.pone.0167432.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
000826171 8564_ $$uhttps://juser.fz-juelich.de/record/826171/files/journal.pone.0167432.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
000826171 8564_ $$uhttps://juser.fz-juelich.de/record/826171/files/journal.pone.0167432.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000826171 909CO $$ooai:juser.fz-juelich.de:826171$$pdnbdelivery$$pVDB$$pdriver$$popen_access$$popenaire
000826171 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145961$$aForschungszentrum Jülich$$b0$$kFZJ
000826171 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)159147$$aForschungszentrum Jülich$$b2$$kFZJ
000826171 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132029$$aForschungszentrum Jülich$$b3$$kFZJ
000826171 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000826171 9141_ $$y2016
000826171 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000826171 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000826171 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000826171 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000826171 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record
000826171 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPLOS ONE : 2015
000826171 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000826171 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000826171 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000826171 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000826171 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000826171 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000826171 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000826171 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000826171 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000826171 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000826171 920__ $$lyes
000826171 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie $$x0
000826171 9801_ $$aFullTexts
000826171 980__ $$ajournal
000826171 980__ $$aVDB
000826171 980__ $$aUNRESTRICTED
000826171 980__ $$aI:(DE-Juel1)ICS-6-20110106
000826171 981__ $$aI:(DE-Juel1)IBI-7-20200312